CN Patent

CN111511749B — 具有大环分子结构的化合物及其用途

Assigned to Shanghai Genbase Biotechnology Co Ltd · Expires 2022-02-08 · 4y expired

What this patent protects

本公开涉及一种通式(I)所示化合物，该化合物是具有大环分子结构的小分子激酶抑制剂，还涉及包含该化合物的药物组合物以及该化合物的治疗用途，

USPTO Abstract

本公开涉及一种通式(I)所示化合物，该化合物是具有大环分子结构的小分子激酶抑制剂，还涉及包含该化合物的药物组合物以及该化合物的治疗用途，

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: CN111511749B
Jurisdiction: CN
Classification: —
Expires: 2022-02-08
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Genbase Biotechnology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.